Over two million people in the United States have hepatitis B, but nearly two-thirds of them aren’t even aware they’re infected. Patients must first have hep B before contracting hepatitis D—the most severe form of chronic hepatitis. With so many people unaware of their hep B status, how many could be in the dark about having hep D, too? With our HepDelta campaign, we wanted to motivate all healthcare providers (HCPs) to screen their hep B patients for hep D. We know that HCPs strive to keep their patients healthy, but they do so much more than that. They spend years—lifetimes, even— developing trust and lasting relationships with their patients. Most people with hep B in the US have emigrated from other countries with high rates of HBV, including parts of Asia and Africa. Building and maintaining these relationships can be invaluable to communities, especially for doctors with patients of immigrant descent. Diagnostic screening of hep D is essential, as it unveils knowledge that allows HCPs to tailor a treatment and management plan, provide insight into patient experiences, and have more informed conversations with those that trust them the most.
Contributors:
Chief Creative Officer: | Dina Peck |
EVP, Group Creative Director, Art: | Michele Monteforte |
EVP, Group Creative Director, Copy: | Stephanie Markell |
VP, Art Supervisor: | Rick Calzi |
VP, Group Account Director: | Lisa Ames |
Copy Supervisor: | Greta Reichert |
Senior Account Executive: | Sandy Raju |
Senior Project Manager: | Lisa Paccagnini |
Group Project Supervisor: | Stephanie Viall |
SCIENCE & PURPOSE
Location: United States